|
1
|
Siller-Matula JM, Schwameis M, Blann A,
Mannhalter C and Jilma B: Thrombin as a multi-functional enzyme.
Focus on in vitro and in vivo effects. Thromb Haemost.
106:1020–1033. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Patterson C, Stouffer GA, Madamanchi N and
Runge MS: New tricks for old dogs: Nonthrombotic effects of
thrombin in vessel wall biology. Circ Res. 88:987–997. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moon SK, Thompson LJ, Madamanchi N,
Ballinger S, Papaconstantinou J, Horaist C, Runge MS and Patterson
C: Aging, oxidative responses and proliferative capacity in
cultured mouse aortic smooth muscle cells. Am J Physiol Heart Circ
Physiol. 280:H2779–H2788. 2001.PubMed/NCBI
|
|
4
|
Galis ZS, Kranzhöfer R, Fenton JW II and
Libby P: Thrombin promotes activation of matrix metalloproteinase-2
produced by cultured vascular smooth muscle cells. Arterioscler
Thromb Vasc Biol. 17:483–489. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smiljanic K, Obradovic M, Jovanovic A,
Djordjevic J, Dobutovic B, Jevremovic D, Marche P and Isenovic ER:
Thrombin stimulates VSMC proliferation through an EGFR-dependent
pathway: Involvement of MMP-2. Mol Cell Biochem. 396:147–160. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen HT, Tsou HK, Tsai CH, Kuo CC, Chiang
YK, Chang CH, Fong YC and Tang CH: Thrombin enhanced migration and
MMPs expression of human chondrosarcoma cells involves PAR receptor
signaling pathway. J Cell Physiol. 223:737–745. 2010.PubMed/NCBI
|
|
7
|
Huang YL, Kou JP, Ma L, Song JX and Yu BY:
Possible mechanism of the anti-inflammatory activity of ruscogenin:
Role of intercellular adhesion molecule-1 and nuclear
factor-kappaB. J Pharmacol Sci. 108:198–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kou J, Sun Y, Lin Y, Cheng Z, Zheng W, Yu
B and Xu Q: Anti-inflammatory activities of aqueous extract from
Radix Ophiopogon japonicus and its two constituents. Biol Pharm
Bull. 28:1234–1238. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kou J, Yu B and Xu Q: Inhibitory effects
of ethanol extract from Radix Ophiopogon japonicus on venous
thrombosis linked with its endothelium-protective and anti-adhesive
activities. Vascul Pharmacol. 43:157–163. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qian J, Jiang F, Wang B, Yu Y, Zhang X,
Yin Z and Liu C: Ophiopogonin D prevents H2O2-induced injury in
primary human umbilical vein endothelial cells. J Ethnopharmacol.
128:438–445. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kou J, Tian Y, Tang Y, Yan J and Yu B:
Antithrombotic activities of aqueous extract from Radix Ophiopogon
japonicus and its two constituents. Biol Pharm Bull. 29:1267–1270.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yan L and Kim IH: Effect of dietary grape
pomace fermented by Saccharomyces boulardii on the growth
performance, nutrient digestibility and meat quality in finishing
pigs. Asian Austral J Anim. 24:1763–1770. 2011. View Article : Google Scholar
|
|
13
|
Choi YK, Sul JU, Park SK, Yu SN, Kim SH,
Rhee MS, Ahn SC and Shin MS: Research trends of fermented medicinal
herbs-based on their clinical efficacy and safety assessment. J
Life Science. 22:1729–1739. 2012. View Article : Google Scholar
|
|
14
|
Moon SK, Cha BY and Kim CH: ERK1/2
mediates TNF-alpha-induced matrix metalloproteinase-9 expression in
human vascular smooth muscle cells via the regulation of NF-kappaB
and AP-1: Involvement of the ras dependent pathway. J Cell Physiol.
198:417–427. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xiong Y, Hannon GJ, Zhang H, Casso D,
Kobayashi R and Beach D: P21 is a universal inhibitor of cyclin
kinases. Nature. 366:701–704. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Toyoshima H and Hunter T: P27, a novel
inhibitor of G1 cyclin-Cdk protein kinase activity, is related to
p21. Cell. 78:67–74. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tanner FC, Yang ZY, Duckers E, Gordon D,
Nabel GJ and Nabel EG: Expression of cyclin-dependent kinase
inhibitors in vascular disease. Circ Res. 82:396–403. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen D, Krasinski K, Sylvester A, Chen J,
Nisen PD and Andrés V: Downregulation of cyclin-dependent kinase 2
activity and cyclin A promoter activity in vascular smooth muscle
cells by p27 (KIP1), an inhibitor of neointima formation in the rat
carotid artery. J Clin Invest. 99:2334–2341. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Besson A, Dowdy SF and Roberts JM: CDK
inhibitors: Cell cycle regulators and beyond. Dev Cell. 14:159–169.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moon SK, Kim HM, Lee YC and Kim CH:
Disialoganglioside (GD3) synthase gene expression suppresses
vascular smooth muscle cell responses via the inhibition of ERK1/2
phosphor-ylation, cell cycle progression and matrix
metalloproteinase-9 expression. J Biol Chem. 279:33063–33070. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhan Y, Kim S, Izumi Y, Izumiya Y, Nakao
T, Miyazaki H and Iwao H: Role of JNK, p38 and ERK in
platelet-derived growth factor-induced vascular proliferation,
migration and gene expression. Arterioscler Thromb Vasc Biol.
23:795–801. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen M, Du Y, Qui M, Wang M, Chen K, Huang
Z, Jiang M, Xiong F, Chen J, Zhou J, et al: Ophiopogonin B-induced
autophagy in non-small cell lung cancer cells via inhibition of the
PI3K/Akt signaling pathway. Oncol Rep. 29:430–436. 2013.
|
|
23
|
Wang LY, Wang Y, Xu DS, Ruan KF, Feng Y
and Wang S: MDG-1, a polysaccharide from Ophiopogon japonicus
exerts hypoglycemic effects through the PI3K/Akt pathway in a
diabetic KKAy mouse model. J Ethnopharmacol. 143:347–354. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guan T, Liu Q, Qian Y, Yang H, Kong J, Kou
J and Yu B: Ruscogenin reduces cerebral ischemic injury via
NF-κB-mediated inflammatory pathway in the mouse model of
experimental stroke. Eur J Pharmacol. 714:303–311. 2013. View Article : Google Scholar : PubMed/NCBI
|
